ORGANIC
LETTERS
2011
Vol. 13, No. 3
353-355
1,3,5-Trisubstituted and
5-Acyl-1,3-Disubstituted Hydantoin
Derivatives via Novel Sequential
Three-Component Reaction
Orazio A. Attanasi, Lucia De Crescentini, Gianfranco Favi, Simona Nicolini,
Francesca Romana Perrulli, and Stefania Santeusanio*
Istituto di Chimica Organica, UniVersita` degli Studi di Urbino “Carlo Bo”, Via I
Maggetti 24, 61029 Urbino, Italy
Received November 3, 2010
ABSTRACT
1,2-Diaza-1,3-dienes (DDs) react as Michael acceptors with primary amines to afford r-aminohydrazone derivatives that were in situ coupled
with isocyanates. Intramolecular ring closure of the asymmetric urea derivatives so formed allows for a selectively substituted hydantoin ring
to be obtained. The hydrazone side chain introduced by the conjugated heterodiene system at the 5-position of the heterocycle represents a
valuable functionality for accessing novel 5-acyl derivatives difficult to obtain by other methods.
Hydantoin-based scaffolds have been found to possess
significant pharmacological activities. In fact, many deriva-
tives have been identified as anticonvulsant,1 antimuscarin-
ics,2 antiulcers and antiarrhythmics,3 antivirals, antidiabetics,4
and serotonin and fibrinogen receptor antagonists.5 Moreover,
substituted hydantoins are important building blocks for the
synthesis of nonnatural amino acids by alkaline degradation.6
Therefore, many methods for the rapid acquisition of
structurally varied and functionalized hydantoins are desir-
able. The synthesis of 1,3,5-trisubstituted hydantoins is
usually accomplished by reacting N-substituted R-amino
acids or their esters with isocyanates, either in solution7 or
in solid phase.8 Other strategies for the synthesis of 1,3,5-
hydantoins have been recently reported in the literature and
are based on the reaction of N,N′-disubstituted ureas with
carbon monoxide and aldehydes,9 on a Ugi four-component
condensation10 and on the reaction between activated R,ꢀ-
unsaturated carboxylic acids and asymmetric carbodiim-
ides.11 To the best of our knowledge, there is no report on
the synthesis of 1,3,5-trisubstituted hydantoins having hy-
drazone or acyl function at the 5-position of the ring neither
(1) Thenmozhiyal, J. C.; Wong, P. T. H.; Chui, W. K. J. Med. Chem.
2004, 47, 1527.
(2) (a) Brazil, C. W.; Pedley, T. A. Annu. ReV. Med. 1998, 49, 135. (b)
Luer, M. S. Neurol. Res. 1998, 20, 178.
(7) (a) Martin, D. J. J. Prakt. Chem. 1991, 333, 261. (b) Atay, E.;
Blogoeva, I. B.; Jirby, A. J.; Pojarieff, I. G. J. Chem. Soc., Perkin Trans.
2 1998, 2289. (c) Blogoeva, I. B.; Toteva, M. M.; Ouarti, N.; Ruasse, M.-
F. J. Org. Chem. 2001, 66, 2123.
(3) (a) Matzukura, M.; Daiku, Y.; Ueda, K.; Tanaka, S.; Igarashi, T.;
Minami, N. Chem. Pharm. Bull. 1992, 40, 1823. (b) Knabe, J.; Baldauf, J.;
Ahlhelm, A. Pharmazie 1997, 52, 912.
(8) (a) Matthews, J.; Rivero, R. A. J. Org. Chem. 1997, 62, 6090. (b)
Kim, S. W.; Ahn, S. Y.; Koh, J. S.; Lee, J. H.; Ro, S.; Cho, H. Y.
Tetrahedron Lett. 1997, 38, 4603. (c) Boeijen, A.; Kruijtzer, J. A. W.;
Liskamp, R. M. J. Bioorg. Med. Chem. Lett. 1995, 5, 47.
(9) Beller, M.; Eckert, M.; Moradi, W. A.; Neumann, H. Angew. Chem.,
Int. Ed. 1999, 38, 1454.
¨
(4) Somsa´k, L.; Kova´cs, L.; To´th, M.; Osz, E.; Szila´gyi, L.; Gyo¨rgydeak,
Z.; Dinya, Z.; Docsa, T.; To´th, B.; Gergely, P. J. Med. Chem. 2001, 44,
2843.
(5) (a) Moloney, G. P.; Robertson, A. D.; Martin, G. R.; MacLennan,
S.; Mathews, N.; Dosworth, S.; Sang, P. Y.; Knight, C.; Glen, R. J. Med.
Chem. 2001, 44, 2843. (b) Moloney, G. P.; Martin, G. R.; Mathews, N.;
Milne, A.; Hobbs, H.; Dosworth, S.; Sang, P. Y.; Knight, C.; Maxwell,
M.; Glen, R. J. Med. Chem. 1999, 42, 2504.
(10) Ignacio, J. M.; Macho, S.; Marcaccini, S.; Pepino, R.; Torroba, T.
Synlett 2005, 3051.
(11) Volonterio, A.; de Arellano, C. R.; Zanda, M. J. Org. Chem. 2005,
70, 2161.
(6) Sutherland, J. C.; Hess, G. P. Nat. Prod. Rep. 2000, 17, 621.
10.1021/ol102664n 2011 American Chemical Society
Published on Web 12/27/2010